Gollard R, Kosty M, Cheney C, Copeland B, Bordin G
Division of Hematology and Medical Oncology, Scripps Clinic and Research Foundation, La Jolla, California 92037, USA.
Cancer. 1995 Nov 15;76(10):1814-20. doi: 10.1002/1097-0142(19951115)76:10<1814::aid-cncr2820761021>3.0.co;2-t.
Prolactin-secreting pituitary carcinomas are uncommon, locally destructive neoplasms that rarely metastasize outside the central nervous system. The authors report a case of a prolactin-secreting tumor that initially presented as the empty sella syndrome. Two recurrences along transsphenoidal surgery tracts in cheek pouches were followed by distant metastases later in the abdomen and pelvis. Only 10 previous cases of either extracranial or intracranial metastases from prolactin-secreting pituitary carcinomas have been reported. No metastases below the diaphragm have been reported previously.
The patient's cheek pouch implants, lymph node metastases, ovarian metastases, and uterine metastases were studied with prolactin-specific immunohistochemistry.
Long term treatment with bromocriptine, several debulking surgeries, extensive local radiation therapy (external beam and proton beam), and cytotoxic chemotherapy had little impact. Tamoxifen, however, may have slowed tumor growth.
Tamoxifen may have efficacy in the treatment of prolactin-secreting pituitary carcinomas.
分泌催乳素的垂体癌较为罕见,是具有局部破坏性的肿瘤,很少在中枢神经系统外发生转移。作者报告了一例最初表现为空蝶鞍综合征的分泌催乳素肿瘤病例。经蝶窦手术通道在颊袋处出现两次复发,随后在腹部和骨盆发生远处转移。此前仅报告过10例分泌催乳素的垂体癌发生颅外或颅内转移的病例。此前未见有横膈以下转移的报道。
采用催乳素特异性免疫组织化学方法对患者的颊袋植入物、淋巴结转移灶、卵巢转移灶和子宫转移灶进行研究。
长期使用溴隐亭治疗、多次减瘤手术、广泛的局部放射治疗(外照射和质子束照射)以及细胞毒性化疗效果甚微。然而,他莫昔芬可能减缓了肿瘤生长。
他莫昔芬可能对分泌催乳素的垂体癌治疗有效。